Research
Mixed
Senolytic drugs (e.g., Dasatinib + Quercetin) reduce senescent cell burden and improve healthspan parameters in aged, radiation-exposed, and progeroid mice, though clinical use is limited by side effects like neutropenia.
Senolytic drugs like Dasatinib and Quercetin show promise in animal models for improving healthspan and reducing senescent cells. However, human application is currently limited by side effects like blood cell count reduction. This is an emerging field, not yet a standard recommendation for healthy individuals.
ModerateSupportsMEDIUM confidence
Given in combination, D + Q reduce senescent cell burden in aged, radiation-exposed and progeroid mice, while improving health span parameters, including cardiovascular and physical function (Xu et al. 2018)... Trials assessing navitoclax as an anticancer agent report neutropenia and thrombocytopenia (Wilson et al. 2010).
Why this rating
Evidence is primarily preclinical (murine models); human trials are mentioned but noted to have significant side effects and limited scope.
Source
Senescence and the SASP: many therapeutic avenues
Jodie Birch et al. · Genes & Development · 2020
DOI 10.1101/gad.343129.120
narrative_reviewCited 1,104×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- SASP modulation (senomorphics) offers an alternative to senolytics by targeting the secretome rather than killing cells, with potential benefits for wound healing and fibrosis where cell clearance might be harmful.Moderate
- Inducing senescence in cancer cells (prosenescence) followed by senolytic clearance ('one-two punch') or immune potentiation can improve cancer treatment outcomes by exploiting vulnerabilities of senescent tumor cells.Moderate
Related findings · Mixed
- Bariatric surgery (VSG and RYGB) is the most effective and sustainable treatment for obesity, producing marked and sustained weight loss that non-surgical interventions cannot match.Strong
- Severely protein-deficient diets (2–3% energy) induce lean body mass loss and metabolic imbalance, whereas adequate protein intake (0.66 g/kg/d minimum) is a prerequisite for maintaining muscle, bone, and physiological function.Strong
- For patients with Class III obesity (BMI >39.9 kg/m2), metabolic bariatric surgery (MBS) is significantly more effective than any currently approved medication, with BilioPancreatic Diversion (BPD) showing the highest estimated weight loss.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →